Gloria Reuben: VEOZAH Eased My Menopause Hot Flashes — SkimNews
Get the Culture newsletter
Daily culture — film, music, books, the trends and ideas worth your attention. Free.
- Gloria Reuben experienced moderate to severe hot flashes for years, saying they disrupted her acting work — from wardrobe decisions on set to feeling disconnected from scene partners and fearing sudden hot flashes on camera.
- Nearly half of women going through menopause experience moderate to severe hot flashes, with Black and Hispanic women disproportionately affected in frequency and severity, per the source.
- VEOZAH (fezolinetant) is the #1 prescribed hormone-free FDA-approved treatment for moderate to severe hot flashes due to menopause, per IQVIA TRx data covering May 2023 to June 2026; it works by blocking NKB binding in the brain's temperature control center.
- Reuben chose VEOZAH after seeing a TV commercial, consulting her doctor, and completing required liver blood tests before and during treatment; she reported a decrease in hot flashes, both day and night, within about a week.
- VEOZAH carries a boxed warning for serious liver side effects, requiring pre-treatment and ongoing blood tests; the source notes users should stop the drug and call their doctor if they experience symptoms like yellowing skin, dark urine, or stomach pain.
- Reuben reframes menopause as "not just a new chapter, it's a new volume," emphasizing self-advocacy and communication with healthcare providers; she has since written her first book, "My Brothers' Keeper," and her first play.
Why it matters: A recognizable entertainment figure lending her voice to menopause symptom treatment could normalize conversations around hot flashes in a topic the source itself calls "misunderstood and underdiscussed," particularly given the disproportionate impact on Black and Hispanic women noted in the piece. VEOZAH's position as the #1 prescribed hormone-free option in its category (per IQVIA TRx, May 2023–June 2026) signals growing demand for non-hormonal alternatives — but the boxed liver warning makes physician monitoring a non-negotiable part of the regimen.
Ask SkimNews
